Premium
Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis
Author(s) -
Xie Guoxiang,
Wang Xiaoning,
Huang Fengjie,
Zhao Aihua,
Chen Wenlian,
Yan Jingyu,
Zhang Yunjing,
Lei Sha,
Ge Kun,
Zheng Xiaojiao,
Liu Jiajian,
Su Mingming,
Liu Ping,
Jia Wei
Publication year - 2016
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.30219
Subject(s) - medicine , bile acid , endocrinology , carcinogenesis , gut flora , liver cancer , hepatocellular carcinoma , biology , azoxymethane , cancer research , cancer , biochemistry
Dysregulated bile acids (BAs) are closely associated with liver diseases and attributed to altered gut microbiota. Here, we show that the intrahepatic retention of hydrophobic BAs including deoxycholate (DCA), taurocholate (TCA), taurochenodeoxycholate (TCDCA), and taurolithocholate (TLCA) were substantially increased in a streptozotocin and high fat diet (HFD) induced nonalcoholic steatohepatitis‐hepatocellular carcinoma (NASH‐HCC) mouse model. Additionally chronic HFD‐fed mice spontaneously developed liver tumors with significantly increased hepatic BA levels. Enhancing intestinal excretion of hydrophobic BAs in the NASH‐HCC model mice by a 2% cholestyramine feeding significantly prevented HCC development. The gut microbiota alterations were closely correlated with altered BA levels in liver and feces. HFD‐induced inflammation inhibited key BA transporters, resulting in sustained increases in intrahepatic BA concentrations. Our study also showed a significantly increased cell proliferation in BA treated normal human hepatic cell lines and a down‐regulated expression of tumor suppressor gene CEBPα in TCDCA treated HepG2 cell line, suggesting that several hydrophobic BAs may collaboratively promote liver carcinogenesis.